ZVIA Company Profile and Key Details

Zevia PBC generated EPS of -$0.23 over the past year. Five-year average earnings growth is -32.77%. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 0 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $6.00 to $6.00. The high target offers 365.12% upside. The low target suggests 365.12% downside. The mean target is $6.00. This offers 365.12% upside. Zevia PBC earnings surprise history is a mixed track record. The quarter that ended August 05, 2026, missed forecasts by 0.0%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include -40.0% in May 07, 2025.

Zevia PBC (NYSE:ZVIA) closed at $1.29 USD, losing -$0.03 (-2.27%) from the previous close of $1.32. The stock is currently mid-range between its 52-week high and low $1.11 and $3.17. With a market capitalization of about $92.59 million, Zevia PBC is classified as a micro-cap and shows market-like volatility (beta ~0.99). Key stats such as the average daily volume over the past year has been around 922.55 thousand shares, volume is running light vs its 52-week average. Headquartered in Encino, CA, Zevia PBC operates in the Consumer Defensive sector and the Beverages - Non-Alcoholic industry. Led by CEO Alexandre Ruberti, the company employs approximately 91 people and listed since July 22, 2021. Zevia PBC operates as a drinks company, involved in the creation, marketing, sale, and supply of various sparkling and still soft beverages across both the United States and Canada.

ZVIA has shown mixed momentum, gaining 4.44% over the past week and -17.18% over the past quarter, though year-to-date performance is down -18.97%. Short-term trend indicators are bullishly aligned (SMA20 -18.33%, SMA50 -30.12%, SMA200 -47.03%). The stock’s 14-day RSI is 28.96 (weak momentum), while the ATR of 0.13 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -63.11% below its high and over -9.09% above its low. Average 10-day trading volume of 368.82 thousand shares is below the 3-month average of 916.44 thousand, indicating normal recent market interest.

Zevia PBC last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.42. This means the shares are trading below this model’s fair value.

Zevia PBC has 64.53 million shares outstanding. The public float is 36.01 million shares, elevated short interest at 5.35% of float. This equals 2.16 million shares. The short ratio is 2.61 days. Institutional investors hold 65.75% of the float. Insiders own 6.5%. CAISSE DE DEPOT ET PLACEMENT DU QUEBEC holds 11.40 million shares, Ripley Rosemary L has 2.72 million shares and Taylor Amy has 2.39 million shares. Over the past six months, insider transactions show net selling. They sold 2.38 million shares across 6 transactions.

Zevia PBC trades at a P/E ratio of -9.9, slightly below the S&P 500 average, with a price-to-sales ratio of 0.56 and a price-to-book ratio of 2.15 suggesting the stock is closer to book value. The P/FCF stands at 32.64, also above market averages.

Zevia PBC (NYSE:ZVIA) shares are down -18.97% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Zevia PBC trading at a premium to the broader market with a P/E of -9.9. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $4.60, suggesting 256.59% upside. Our AI forecast model points to short-term weakness (-17.83% over two weeks), a medium-term fall (-23.26% over three months), and a longer-term gain (151.16% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Zevia PBC stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -17.83%, with price expected at $1.06 by September 03, 2026, within a range of $0.97 to $1.15 3-Month Outlook: Projected fall of -23.26%, reaching $0.99 by November 18, 2026, with a range of $0.91 to $1.06. 1-Year Outlook: Projected gain of 151.16%, with price at $3.24 by August 20, 2027, within a range of $0.00 to $2.90.